Iasis Molecular Sciences is pleased to announce that the company will join Life Science Washington Institute (LSWI) and Baxter for a Venture Investment & Partnering Forum on August 21, 2019. Baxter is looking to partner with companies that have innovative technologies and therapies helping to advance patient care.
by Mark Vachon